Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AngioDynamics, a provider of medical devices for treatment of cancer and peripheral vascular disease, has acquired certain US and UK assets of Diomed.
Subscribe to our email newsletter
The purchase price for the assets is $11 million subject to adjustment for changes in working capital to be determined subsequent to the closing date.
Eamonn Hobbs, president and CEO of AngioDynamics, said: “With the acquisition of Diomed’s assets, AngioDynamics has substantially strengthened its position in the worldwide market for the treatment of varicose veins.”